2,2-二甲氧基-1-哌啶-1-乙酮 | 16695-59-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 2,2-二甲氧基-1-哌啶-1-乙酮
• 英文名称: N-(2,2-dimethoxyacetyl)piperidine
• 英文别名: 1-(dimethoxyacetyl)piperidine；1-dimetoxiacetilpiperidina；1-dimethoxyacetyl-piperidine；1-piperidineglyoxaldehyde dimethylacetal；dimethoxyacetic acid piperidide；dimethoxyacetyl piperidide；2,2-Dimethoxy-1-(piperidin-1-yl)ethanone；2,2-dimethoxy-1-piperidin-1-ylethanone
• CAS: 16695-59-3
• 化学式: C₉H₁₇NO₃
• mdl: MFCD08689667
• 分子量: 187.239
• InChiKey: WQAKEXCQFZNEFH-UHFFFAOYSA-N

物化性质

• 沸点：
  72/0.01mm

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.888
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312+P330,P302+P352+P312,P304+P340+P312,P363,P501
• 危险性描述：
  H302+H312+H332

反应信息

• 作为反应物：
  描述：

  3-氯吡啶 、 2,2-二甲氧基-1-哌啶-1-乙酮 在 三乙烯二胺 、 正丁基锂 作用下， 以 乙醚 、 正己烷 为溶剂， 反应 2.17h， 以54%的产率得到1-(3-chloropyridin-2-yl)-2,2-dimethoxyethanone
  参考文献：
  名称：

  [EN] SUBSTITUTED AMINO HETEROCYCLES AS VR-1 ANTAGONISTS FOR TREATING PAIN
  [FR] AMINO-HETEROCYCLES SUBSTITUES EN TANT QU'ANTAGONISTES DU VR-1 POUR TRAITER LA DOULEUR

  摘要：

  本发明提供了式I的化合物：其中：T1和T4中的一个是N，另一个是C; T2和T3独立地是N或C（CH2）nR2; X，Y和Z独立地是N或C（CH2）nR3; R1是Ar1或R1是C1-6烷基，可选地取代一个或两个Ar1基团; Ar1是可选取代的环己基，哌啶基，哌嗪基，吗啉基，金刚烷基，苯基，萘基，一个六元杂环芳香环，其中含有一个，两个或三个氮原子，一个五元杂环芳香环，其中选择了一个，两个，三个或四个杂原子从O，N和S中选择，最多只有一个O或S原子存在，或一个九元或十元的双环杂芳香环，其中苯基或上述定义的六元杂环芳香环与上述定义的六元或五元杂环芳香环融合; Ar是可选取代的苯基，一个含有一个，两个或三个氮原子的六元杂环芳香环或一个含有一个，两个，三个或四个从O，N和S中选择的杂原子的五元杂环芳香环，最多只有一个杂原子是O或S，Ar可选地取代由卤素，CF3，OCF3，C1-6烷基，C2-6烯基，C2-6炔基，硝基，氰基，异腈基，羟基，C1-6烷氧基，C1-6烷基硫基，-NR6R7，-CONR6R7，-COH，CO2H，C1-6烷氧羰基，卤代C1-6烷基，羟基C1-6烷基，氨基C1-6烷基，C1-6烷基羰基和一个含有一个，两个，三个或四个从O，N和S中选择的杂原子的五元杂环芳香环，最多只有一个杂原子是O或S，可选地被C1-6烷基，卤素，氨基，羟基或氰基取代;或其药学上可接受的盐作为VR-1配体;包含它的制药组合物;其在治疗中的用途;将其用于制造治疗疼痛的药物;以及治疗患有疼痛的受试者的方法。

  公开号：

  WO2004074290A1
• 作为产物：
  描述：

  氯仿 、 methyl (E)-3-(N-piperidyl)-4,4-dimethoxybut-2-enoate 在 sodium hydroxide 、 苄基三乙基氯化铵 作用下， 以14%的产率得到2,2-二甲氧基-1-哌啶-1-乙酮
  参考文献：
  名称：

  Ancos, B. de; Farina, F.; Maestro, M. C., Anales de Quimica, 1995, vol. 91, # 1.2, p. 132 - 141

  摘要：

  DOI：

文献信息

• Approaches to the synthesis of cytochalasans. Part 7. Synthesis of some building blocks for the construction of the macrocyclic moiety
  作者：Daniel Wallach、Ivan G. Csendes、Peter E. Burckhardt、Tibur Schmidlin、Christoph Tamm

  DOI：10.1002/hlca.19840670737

  日期：1984.11.7

  The synthesis of ethyl (2E, 4E, 8R)-8-methyl-10-[(2H-tetrahydropyran-2-yl)oxy]-2,4-decadienoate (11), methyl (2E, 8R)-8-methyl-10-[(2H-tetrahydropyran-2-yl)oxy]-2-decenoate (16), synthons for the construction of the macrocyclic moieties of the cytochalasins A, B and F, and of (3R)-[7-(1,3-dioxolan-2-yl)-3-methylheptyl]triphenyl-phosphonium bromide (24), a C8-building block for deoxaphomin, proxiphomin

  （2 E，4 E，8 R）-8-甲基-10-[（2 H-四氢吡喃-2-基）氧基] -2,4-癸二烯酸酯的合成（11），甲基（2 E，8 R）-8-甲基-10-[（2 H-四氢吡喃-2-基）氧基] -2-癸烯酸酯（16），用于构建细胞松弛素A，B和F的大环部分以及（描述了3 R）-[7-（1,3-二氧杂戊-2-基）-3-甲基庚基]三苯基-溴化phosph （24），它是脱氧磷，原磷和原磷的C 8砌块。在所有情况下（+）-（R）-pulegone（5）作为起始材料。
• 3-substituted pyridinemethanols and fungicides containing them
  申请人：BASF Aktiengesellschaft

  公开号：US05196433A1

  公开（公告）日：1993-03-23

  Compounds of the Formula ##STR1## where R is alkyl or cycloalkyl, X,Y,Z are hydrogen, halogen, alkyl, alkoxy, alkoximino, haloalkyl, cyano, niro or substituted or unsubstituted phenyl or phenoxy, W is a single bond or one of the groups --CH.sub.2 --, --CH(CH.sub.3)-- or --CH.sub.2 CH.sub.2 -- and n is 0 or 1, and plant-tolerated acid addition salts thereof, and fungicides containing these compounds.

  化学式为##STR1##的化合物，其中R为烷基或环烷基，X、Y、Z为氢、卤素、烷基、烷氧基、烷氧肟基、卤代烷基、氰基、硝基或取代或未取代的苯基或苯氧基，W为单键或--CH.sub.2 --、--CH(CH.sub.3)--或--CH.sub.2 CH.sub.2 --中的一种基团，n为0或1，以及植物耐受的酸盐加合物和含有这些化合物的杀菌剂。
• Substituted amino heterocycles as vr-1 antagonists for treating pain
  申请人：Brown Elizabeth Rebecca

  公开号：US20060154930A1

  公开（公告）日：2006-07-13

  The present invention provides compounds of formula I: in which: one of T 1 and T 4 is N and the other is C; T 2 and T 3 are independently N or C(CH 2 ) n R 2 ; X, Y and Z are independently N or C(CH 2 ) n R 3 ; R 1 is Ar 1 or R 1 is C 1-6 alkyl optionally substituted with one or two groups Ar1; Ar1 is an optionally substituted cyclohexyl, piperidinyl, piperazinyl, morpholinyl, adamantyl, phenyl, naphthyl, a six membered heteroaromatic ring containing one, two or three nitrogen atoms, a five-membered heteroaromatic ring containing one, two, three or four heteroatoms chosen from O, N and S, at most one O or S atom being present, or a nine- or ten-membered bicyclic heteroaromatic ring in which phenyl or a six-membered heteroaromatic ring as defined above is fused to a six- or five-membered heteroaromatic ring as defined above; Ar is an optionally substituted phenyl, a six-membered heteroaromatic ring containing one, two or three nitrogen atoms or a five-membered heteroaromatic ring containing one, two, three or four heteroatoms chosen from O, N and S, at most one heteroatom being O or S, Ar being optionally substituted by one, two or three groups chosen from halogen, CF 3 , OCF 3 , C 1-6 -alkyl, C 2-6 alkenyl, C 2-6 alkynyl, nitro, cyano, isonitrile, hydroxy, C 1-6 alkoxy, C 1-6 alkylthio, —NR 6 R 7 , —CONR 6 R 7 , —COH, CO 2 H, C 1-6 alkoxycarbonyl, haloC 1-4 alkyl, hydroxyC 1-6 alkyl, aminoC 1-6 alkyl, C 1-4 alkylcarbonyl and a five-membered heteroaromatic ring containing one, two, three or four heteroatoms chosen from O, N and S, at most one heteroatom being O or S, optionally substituted by C 1-6 alkyl, halogen, amino, hydroxy or cyano; or a pharmaceutically acceptable salt thereof as a VR-1 ligand; pharmaceutical compositions comprising it; its use in therapy; use of it in the manufacture of a medicament to treat pain; and methods of treating subjects suffering from pain.

  本发明提供了公式I的化合物：其中：T1和T4中的一个是N，另一个是C; T2和T3分别是N或C（CH2）nR2; X，Y和Z分别是N或C（CH2）nR3; R1是Ar1或R1是C1-6烷基，可选地取代一个或两个Ar1基团; Ar1是可选地取代的环己基，哌啶基，哌嗪基，吗啉基，金刚烷基，苯基，萘基，含有一个，两个或三个氮原子的六元杂环芳烃环，含有一，两，三或四个O，N和S杂原子的五元杂环芳烃环，最多只有一个O或S原子存在，或者是将苯基或上述定义的六元杂环芳烃环与上述定义的六元或五元杂环芳烃环融合而成的九元或十元双环杂环芳烃环; Ar是可选地取代的苯基，含有一个，两个或三个氮原子的六元杂环芳烃环或含有一，两个，三个或四个O，N和S杂原子的五元杂环芳烃环，最多只有一个杂原子为O或S，Ar可被一，两或三个由卤素，CF3，OCF3，C1-6烷基，C2-6烯基，C2-6炔基，硝基，氰基，异腈基，羟基，C1-6烷氧基，C1-6烷基硫基，-NR6R7，-CONR6R7，-COH，CO2H，C1-6烷氧基羰基，卤代C1-4烷基，羟基C1-6烷基，氨基C1-6烷基，C1-4烷基羰基和含有一，两个，三个或四个O，N和S杂原子的五元杂环芳烃环取代的基团取代;或其药学上可接受的盐作为VR-1配体;包含它的制药组合物;其在治疗中的应用;将其用于制造治疗疼痛的药物;以及治疗疼痛患者的方法。
• First synthesis of (±)-10β-hydroxy-13β-methylcyclohexa[a]quinolizidine. A convenient route to the ABC-part of 8-azasteroids
  作者：Sylvain Célanire、Isabelle Salliot-Maire、Pierre Ribéreau、Alain Godard、Guy Quéguiner

  DOI：10.1016/s0040-4020(99)00497-4

  日期：1999.7

  The first synthesis of racemic 10 beta-hydroxy-13 beta-methylcyclohexa[a]quinolizidine is reported. Original construction of AC-bicyclic system is achieved by lateral metallation of 2-ethylpyridine followed by a Robinson annelation, with the creation of a quaternary picolinic carbon center. Functionalization of the A-ring and construction of the B-ring by a stereocontrolled reduction of the pyridinium salt and final hydrogenations afford the ABC-part of an 8-azasteroid. (C) 1999 Elsevier Science Ltd. All rights reserved.
• [EN] SUBSTITUTED AMINO HETEROCYCLES AS VR-1 ANTAGONISTS FOR TREATING PAIN<br/>[FR] AMINO-HETEROCYCLES SUBSTITUES EN TANT QU'ANTAGONISTES DU VR-1 POUR TRAITER LA DOULEUR
  申请人：MERCK SHARP & DOHME

  公开号：WO2004074290A1

  公开（公告）日：2004-09-02

  The present invention provides compounds of formula I: in which: one of T1 and T4 is N and the other is C; T2 and T3 are independently N or C(CH2)nR2; X, Y and Z are independently N or C(CH2)nR3; R1 is Ar1 or R1 is C1-6alkyl optionally substituted with one or two groups Ar1; Ar1 is an optionally substituted cyclohexyl, piperidinyl, piperazinyl, morpholinyl, adamantyl, phenyl, naphthyl, a six-membered heteroaromatic ring containing one, two or three nitrogen atoms, a five-membered heteroaromatic ring containing one, two, three or four heteroatoms chosen from O, N and S, at most one O or S atom being present, or a nine- or ten-membered bicyclic heteroaromatic ring in which phenyl or a six-membered heteroaromatic ring as defined above is fused to a six-or five-membered heteroaromatic ring as defined above; Ar is an optionally substituted phenyl, a six-membered heteroaromatic ring containing one, two or three nitrogen atoms or a five-membered heteroaromatic ring containing one, two, three or four heteroatoms chosen from O, N and S, at most one heteroatom being O or S, Ar being optionally substituted by one, two or three groups chosen from halogen, CF3, OCF3, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, nitro, cyano, isonitrile, hydroxy, C1-6alkoxy, C1-6alkylthio, -NR6R7, -CONR6R7, -COH, CO2H, C1-6alkoxycarbonyl, haloC1-6alkyl, hydroxyC1-6alkyl, aminoC1-6alkyl, C1-6alkylcarbonyl and a five-membered heteroaromatic ring containing one, two, three or four heteroatoms chosen from O, N and S, at most one heteroatom being O or S, optionally substituted by C1-6alkyl, halogen, amino, hydroxy or cyano; or a pharmaceutically acceptable salt thereof as a VR-1 ligand; pharmaceutical compositions comprising it; its use in therapy; use of it in the manufacture of a medicament to treat pain; and methods of treating subjects suffering from pain.

  本发明提供了式I的化合物：其中：T1和T4中的一个是N，另一个是C; T2和T3独立地是N或C（CH2）nR2; X，Y和Z独立地是N或C（CH2）nR3; R1是Ar1或R1是C1-6烷基，可选地取代一个或两个Ar1基团; Ar1是可选取代的环己基，哌啶基，哌嗪基，吗啉基，金刚烷基，苯基，萘基，一个六元杂环芳香环，其中含有一个，两个或三个氮原子，一个五元杂环芳香环，其中选择了一个，两个，三个或四个杂原子从O，N和S中选择，最多只有一个O或S原子存在，或一个九元或十元的双环杂芳香环，其中苯基或上述定义的六元杂环芳香环与上述定义的六元或五元杂环芳香环融合; Ar是可选取代的苯基，一个含有一个，两个或三个氮原子的六元杂环芳香环或一个含有一个，两个，三个或四个从O，N和S中选择的杂原子的五元杂环芳香环，最多只有一个杂原子是O或S，Ar可选地取代由卤素，CF3，OCF3，C1-6烷基，C2-6烯基，C2-6炔基，硝基，氰基，异腈基，羟基，C1-6烷氧基，C1-6烷基硫基，-NR6R7，-CONR6R7，-COH，CO2H，C1-6烷氧羰基，卤代C1-6烷基，羟基C1-6烷基，氨基C1-6烷基，C1-6烷基羰基和一个含有一个，两个，三个或四个从O，N和S中选择的杂原子的五元杂环芳香环，最多只有一个杂原子是O或S，可选地被C1-6烷基，卤素，氨基，羟基或氰基取代;或其药学上可接受的盐作为VR-1配体;包含它的制药组合物;其在治疗中的用途;将其用于制造治疗疼痛的药物;以及治疗患有疼痛的受试者的方法。